Prevalence of human immunodeficiency virus-1 drug-resistant mutations among adults on first- and second-line antiretroviral therapy in a resource-limited health facility in Busia County, Kenya

INTRODUCTION: in Kenya, about 1.5 million people are living with the Human Immunodeficiency Virus (HIV). Antiretroviral therapy aids in viral suppression. However, drug-resistance threaten the gains of the HIV infection control program. To determine the prevalence of HIV-1 drug-resistant mutations a...

Descripción completa

Detalles Bibliográficos
Autores principales: Makwaga, Olipher, Adhiambo, Maureen, Mulama, David Hughes, Muoma, John, Adungo, Ferdinard, Wanjiku, Humphrey, Ongaya, Asiko, Maitha, Geoffrey Mutisya, Mwau, Matilu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896523/
https://www.ncbi.nlm.nih.gov/pubmed/33654530
http://dx.doi.org/10.11604/pamj.2020.37.311.25909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896523/
https://www.ncbi.nlm.nih.gov/pubmed/33654530
http://dx.doi.org/10.11604/pamj.2020.37.311.25909

Ejemplares similares